Generic Products

Published Online: Wednesday, February 15, 2012

Methylphenidate Hydrochloride Extended-release Capsules (la)

Marketed by: Actavis (Morristown, NJ)

Compared to: Ritalin (Novartis)

Indication: The FDA approved methylphenidate hydrochloride extended-release capsules (LA), a central nervous system stimulant, for the treatment of attention-deficit/hyperactivity disorder. Actavis has first-to-file exclusivity on the 20-, 30-, and 40-mg strengths. Methylphenidate hydrochloride extended-release capsules (LA) are administered orally once daily in the morning. Alternately, the capsule contents may be sprinkled on a small amount of applesauce and immediately consumed. Methylphenidate hydrochloride extended-release capsules (LA) should not be administered to children younger than 6 years, as safety and efficacy in this age group has not been established.

Dosage Form: Capsules: 20, 30, and 40 mg

For More Information: www.actavis.us

PréNata

Marketed by: Sancilio & Company, Inc (Riviera Beach, FL)

Indication: Sancilio & Company, Inc announced the release of PréNata, a generic prenatal multivitamin indicated to provide vitamin and mineral supplementation throughout pregnancy and during the postnatal period for both lactating and nonlactating mothers. The fruit-flavored tablets are also useful for improving nutritional status prior to conception. The recommended dosage is 1 tablet daily with a meal. The chewable formulation provides an alternative to patients who experience nausea from large or difficult-to-swallow tablets. Patients can also crush PréNata tablets to take with food or swallow with water without affecting their nutritional value.

Dosage Form: Chewable tablets in 90-count bottles

For More Information: www.sancilio.com

Clobetasol Propionate Shampoo, 0.05%

Marketed by: Sandoz (Princeton, NJ)

Compared to: Clobex Shampoo, 0.05% (Galderma Laboratories)

Indication: Sandoz announced the availability of their authorized generic clobetasol propionate shampoo, 0.05%, in the United States. Clobetasol propionate shampoo, 0.05%, is a topical corticosteroid indicated for the treatment of moderate to severe forms of scalp psoriasis in patients 18 years and older. Treatment with clobetasol propionate shampoo, 0.05%, should be limited to 4 weeks because of its potential to suppress the hypothalamic-pituitary-adrenal axis. The total dosage should not exceed 50 g (50 mL or 1.75 fl oz) per week.

Dosage Form: Shampoo: supplied in 4–fl oz bottles

For More Information: www.us.sandoz.com

Lamivudine and Zidovudine Tablets USP

Marketed by: Teva Pharmaceuticals (North Wales, PA)

Compared to: Combivir Tablets (ViiV Healthcare)

Indication: Teva Pharmaceuticals announced the introduction and availability of lamivudine and zidovudine tablets USP, which are AB rated and bioequivalent to Combivir Tablets. Lamivudine and zidovudine tablets are a combination of 2 nucleoside analogue reverse transcriptase inhibitors indicated for the treatment of HIV-1 infection. The dosage for adults and adolescents weighing 30 kg or more is 1 tablet twice daily. Pediatric dosing should be based on body weight and should not exceed adult dosing. This fixed-dose product should not be used in pediatric patients weighing less than 30 kg, or in patients requiring dose adjustment.

Dosage Form: Tablets: 150/300 mg lamivudine/zidovudine

For More Information: www.tevausa.com 



Latest Articles
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.
Chronic kidney disease incidence has grown faster than many of its common comorbidities such as diabetes and hypertension, and medications may be an underappreciated driver of this growth.
President Barack Obama’s fiscal year 2017 budget proposal calls for an additional $1.1 billion to combat the nation’s spiraling opioid epidemic.
Baxter International is voluntarily recalling intravenous solution due to leaking containers and the potential for particulate matter.
Latest Issues
$auto_registration$